Indication

Hereditary Tyrosinemia

1 clinical trial

1 product

Clinical trial

A Prospective, Non-interventional, Post-Marketing Study to Describe Outcome of Nitisinone Treatment in Hereditary Tyrosinemia Type 1 (HT-1) Patients in Routine Clinical Care in China

Status: Recruiting, Estimated PCD: 2027-06-30

Product